


|
Michel Rubinstein
|
|||
Nom : RUBINSTEIN
Prénom : Michel
Date de naissance : 20.10.1957
1969 - 1975 : Athénée Royal de Charleroi (Section Latin-Mathématiques)
1975 - 1982 : Etudes de Médecine à l'Université
Libre de Bruxelles (U.L.B.)
(5 G.D ; 2 L.P.G.D. ; 1 Prix Fl. Mercier)
1982 - 1985 : Licence en Médecine Interne à l'Hôpital Erasme
1985 - 1988 : Licence en Médecine Nucléaire
à l'U.L.B.
Reconnu nucléariste le 26.06.1988
1985 - 1986 : Licence Spéciale en Radioprotection à l'U.L.B.
05/02-10/02 : Formation en PET-SCAN (ULB Erasme - professeur S. Goldman)
- 1988 à ce jour : Département de Médecine Nucléaire de l'Hôpital d'Ixelles
- Depuis 11/1993 : Responsable de ce Département.
- Depuis 1992 : Responsable du Département de Médecine Nucléaire du Site Brien Hôpital Brugmann.
- Depuis 1997 : Expert près le Tribunal du Travail de Bruxelles
Egalement Administrateur de la Clinique Antoine Depage.
Manuel de Médecine Nucléaire :
M. Rubinstein, E. Laurent, M. Stegen
Ed. De Boeck Université, 2000
Quantification of the age-dependent changes in cerebral metabolites
: neonatal and hypothyroid rats.
M. Rubinstein & al.
In " Characterization of Biological Tissues by MNR ", EEC Press,
1998.
Desferrioxamine Ocular Toxicity and Chronic Renal Failure.
M. Rubinstein & al. - The Lancet, 1985, 1, 817-818.
Longitudinal Observation of Seasonal Variations of Platelet
Serotonin Uptake and Imipramine Binding in Normal and Depressed Subjects.
M. Rubinstein, D. Egrise, & al. - Biol. Psych., 1986, 4, 758-766.
Mesure du volume ventriculaire gauche au moyen d'un standard
interne et d'une incidence.
M. Rubinstein & al. - J. Biophys. et Bioméc., 1987 , 11,
2.
The Validity of P31-MRS as a Tool for the Study of Congenital
Hypothyroidism in Neonate Rats.
M. Rubinstein & al. In " Research in Congenital Hypothyroidism
", NATO ASI Series, 1988, p. 321.
Single Photon Emission Computed Tomography in Seizure Disorders.
M. Rubinstein, R. Denays, & al. - Archives of Disease in Childhood,
1988, 63, 1184-1188.
Functional Imaging of Brain Maturation in Humans Using 123I-IMP
and SPECT.
M. Rubinstein & al. The Journal of Nuclear Medicine, 1989, 30,
1982-1985.
Evaluation of Suspected Dementia.
M. Rubinstein & al., N. Eng. J. Med., 1996, p. 1997 (letter).
Adherence to Imaging Protocol and Impact of Training on the
Interpretation of CEA-Scan (Arcitumomab) Imaging for colorectal Cancer.
M. Rubinstein, M. VanDaele, P. Wegener; Alasbimn Jounal 6(25) : july
2004.
Clinical Use of Prostaglandin Synthesis Inhibitors in SIADH.
M. Rubinstein & al., XXIInd Congress of the EDTA-European Renal
Association, 1985.
The Pronostic Value of Various Liver Testss in Alcoolic Liver
Cirrhosis.
M. Rubinstein & al., European Nuclear Medicine Congress, Budapest,
1987.
A P31-MRS Study of Congenital Hypothyroidism in Neonate Rats.
M. Rubinstein & al., American Academy of Neurology, XXXth Annual
Meeting, Cincinnati, 1988.
Brain Maturation in Human Newborns : a Cerebral Blood Flow
(CBF) Study Using 123I-IMP and SPECT.
M. Rubinstein & al., The Society of Nuclear Medicine, 35th Meeting,
San Francisco, 1988.
Cerebral Blood Flow Imaging of Brain Maturation in Humans
Using 123I-IMP and SPECT.
M. Rubinstein & al., European Nuclear Medicine Congress, Milano,
1988.
SPECT Study of Cerebral Blood Flow (CBF) Perturbations in
Childhood Seizure Disorders.
M. Rubinstein & al., European Nuclear Medicine Congress, Milano,
1988.
Tc-99m-Nanocolloids : an Alternative Approach to Diagnosis
of Inflammatory Lesions of Bones and Joints.
M. Rubinstein & al., European Nuclear Medicine Congress, Milano,
1988.
Combined CBF/CBV SPECT Study in Recent and Old Strokes .
M. Rubinstein & al., The Society of Nuclear Medicine, 36th Meeting,
Saint-Louis, 1989.
Remote Cortical Effects of Deep Lesions Involving the Pyramidal
Tract : a rCBF Study Using 99mTc-HMPAO.
M. Rubinstein & al., 5th World Congress of Nuclear Medicine and
Biology, Montreal, 1990.
Interactive 3-D Display in 99mTc-HMPAO Brain SPECT.
M. Rubinstein & al., 5th World Congress of Nuclear Medicine and
Biology, Montreal, 1990.
Has 99mTc-HMPAO Brain SPECT a Place in the Routine Work-up
of Epilepsy ?
M. Rubinstein & al., 5th World Congress of Nuclear Medicine and
Biology, Montreal, 1990.
Combined CBF/CBV SPECT Study in Recent and Old Strokes.
M. Rubinstein & al., 5th World Congress of Nuclear Medicine and
Biology, Montreal, 1990.
Left Ventricular Wall Thickening Measurement Using Tc-99m-MIBI
and Gated SPECT : Feasibility and Comparison with Other Imaging Techniques.
M. Rubinstein & al. - 5th World Congress of Nuclear Medicine
and Biology, Montreal, 1990.
Evaluation of Tc-99m HMPAO Brain SPECT (SPECT) In Minor Closed
Head Traumas (MCHT) and Comparison with EERG.
M. Rubinstein & al. - The Society of Nuclear Medicine, 41st Annual
Meeting, Orlando, 1994.
Clinical Assessment of Liver Function and Porto-Systemic Shunt
: a Quantitative 99mTc-IDA Hepatobiliary Scintigraphic (Q-HBS) Study.
M. Rubinstein & al., The Society of Nuclear Medicine, 42nd Annual
Meeting, Minneapolis, 1995.
Comparison of CBV/CBF SPECT and Diamox 99mTc ECD SPECT in
Patients with Unilateral Carotid Stenosis.
M. Rubinstein & al., The Society of Nuclear Medicine, 43rd Meeting,
Denver, 1996.
Impact of Training on the Interpretation of CEA-scan of Patients
with Colo-Rectal Cancer.
M. Rubinstein & al., Annual Meeting of the Eur. Assoc. Of Nuclear
Medicine, Berlin, 1998 (Invited Lecturer).